Frequently Asked Questions
The market is segmented based on , By Method (Conventional/Manual Methods and Automated Methods), Product (Consumables, Instruments and Software and Services), Technology (Culture-Based Technology, Molecular Technologies and Proteomics Technology), Application (Bacteraemia, Fungaemia and Mycobacterial Detection), End-User (Hospital Laboratories, Reference Laboratories, Academic Research Laboratories and Other Laboratories) – Industry Trends and Forecast to 2031.
.
The Global Blood Culture Test Market size was valued at USD 5.19 USD Billion in 2023.
The Global Blood Culture Test Market is projected to grow at a CAGR of 6% during the forecast period of 2024 to 2031.
The major players operating in the market include BD (U.S.), Abbott (U.S.), F. Hoffmann-La Roche Ltd (Switzerland), Novartis AG (Switzerland), Eli Lilly and Company (U.S.), Terumo Corporation (Japan), Bruker (U.S.), BIOMÉRIEUX (France), Bayer AG (Germany), Merck & Co. Inc. (U.S.), Thermo Fisher Scientific Inc. (U.S.), Siemens Healthcare Private Limited (Germany), Danaher Corporation (U.S.), ZEPTOMETRIX (U.S.), CytoTest Inc. (U.S.), and Devyser (Sweden).
The market report covers data from the U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America..
